WallStreetZenWallStreetZen

NASDAQ: COAG
Hemab Therapeutics Holdings Revenue

OverviewEarningsRevenue
DividendOwnership
Hemab Therapeutics Holdings revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, COAG annual revenue was $0.0, with N/A growth year-over-year.

COAG revenue history

Current Revenue
$0.0
Current Earnings
-$63.9M
Current Profit Margin
0%

Be the first to know when COAG announces revenue.

COAG Revenue History By Year

COAG Yearly RevenueCOAG RevenueCOAG ChangeCOAG Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A

1 of 1

Hemab Therapeutics Holdings Revenue FAQ

What was COAG's revenue last quarter?

Hemab Therapeutics Holdings (NASDAQ: COAG) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Hemab Therapeutics Holdings's revenue was N/A.

What was Hemab Therapeutics Holdings's revenue in 2025?

Hemab Therapeutics Holdings's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Hemab Therapeutics Holdings make in a day?

Based on Hemab Therapeutics Holdings annual revenue for the past one years, COAG makes an average of $0.00 per day.

What was Hemab Therapeutics Holdings's annual revenue growth in the past year?

As of Q2 2026, Hemab Therapeutics Holdings's revenue has grown null year over year. Hemab Therapeutics Holdings's revenue in the past year totaled $0.00.

How much does Hemab Therapeutics Holdings make in a year?

Hemab Therapeutics Holdings's revenue by year for the past one years is:
  • Hemab Therapeutics Holdings's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.